The Impact of Ultrasound Contrast Medium Administration on the Right Ventricle in Patients with Heart Failure

Article Figures & Data

Download figure
Open in new tab
Download powerpoint
Figure 1.
The effect of low- and high-doses of SonoVue on right ventricular end-diastolic dimension (RV-EDD) in patients with heart failure and controls. Both low- and high-doses of SonoVue produced a significant increase in RV-EDD from the baseline values in the control group and in patients with heart failure. Baseline, RV-EDD before low-dose contrast administration; Baseline 2, RV-EDD before high-dose contrast administration; Low-dose maximum, the maximum RV-EDD during the low-dose administration; High-dose maximum, the maximum RV-EDD during the high-dose administration.
Download figure
Open in new tab
Download powerpoint
Figure 2.
Diagram depicting the effects of low- and high-dose on right ventricular end-diastolic dimension (RV-EDD) and its time course pattern to maximum and to recovery in patients with heart failure (group A) and to the control group (group B). High-dose administration in both groups produced a significantly greater change in RV-EDD, time duration to maximum and time duration to recovery of RV-EDD in comparison to low-dose administration (Table III).